Your browser doesn't support javascript.
loading
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert Consensus.
Ortiz de Lejarazu-Leonardo, Raul; Montomoli, Emanuele; Wojcik, Radek; Christopher, Solomon; Mosnier, Anne; Pariani, Elena; Trilla Garcia, Antoni; Fickenscher, Helmut; Gärtner, Barbara C; Jandhyala, Ravi; Zambon, Maria; Moore, Catherine.
Affiliation
  • Ortiz de Lejarazu-Leonardo R; Valladolid National Influenza Centre, Calle Rondilla de Santa Teresa s/n, 47009 Valladolid, Spain.
  • Montomoli E; Department of Molecular Medicine, University of Siena, 53100 Siena, Italy.
  • Wojcik R; Medialis Ltd., Banbury OX16 0AH, UK.
  • Christopher S; Medialis Ltd., Banbury OX16 0AH, UK.
  • Mosnier A; Open Rome, 75008 Paris, France.
  • Pariani E; Department of Biomedical Science for Health, University of Milan, 20122 Milan, Italy.
  • Trilla Garcia A; Preventive Medicine and Epidemiology, Hospital Clínic, University of Barcelona, 08007 Barcelona, Spain.
  • Fickenscher H; Institute for Infection Medicine, Kiel University, 24118 Kiel, Germany.
  • Gärtner BC; University Medical Center Schleswig-Holstein, 24105 Kiel, Germany.
  • Jandhyala R; Institute for Microbiology and Hygiene, Saarland University, Faculty of Medicine and Medical Center, Building 43, 66421 Homburg/Saar, Germany.
  • Zambon M; Medialis Ltd., Banbury OX16 0AH, UK.
  • Moore C; Public Health England, London SE1 8UG, UK.
Vaccines (Basel) ; 9(11)2021 Oct 29.
Article in En | MEDLINE | ID: mdl-34835186
BACKGROUND: Influenza vaccines are the main tool to prevent morbidity and mortality of the disease; however, egg adaptations associated with the choice of the manufacturing process may reduce their effectiveness. This study aimed to estimate the impact of egg adaptations and antigenic drift on the effectiveness of trivalent (TIV) and quadrivalent (QIV) influenza vaccines. METHODS: Nine experts in influenza virology were recruited into a Delphi-style exercise. In the first round, the experts were asked to answer questions on the impact of antigenic drift and egg adaptations on vaccine match (VM) and influenza vaccine effectiveness (IVE). In the second round, the experts were presented with the data from a systematic literature review on the same subject and aggregated experts' responses to round one questions. The experts were asked to review and confirm or amend their responses before the final summary statistics were calculated. RESULTS: The experts estimated that, across Europe, the egg adaptations reduce, on average, VM to circulating viruses by 7-21% and reduce IVE by 4-16%. According to the experts, antigenic drift results in a similar impact on VM (8-24%) and IVE (5-20%). The highest reduction in IVE was estimated for the influenza virus A(H3N2) subtype for the under 65 age group. When asked about the frequency of the phenomena, the experts indicated that, on average, between the 2014 and 19 seasons, egg adaptation and antigenic drift were significant enough to impact IVE that occurred in two and three out of five seasons, respectively. They also agreed that this pattern is likely to reoccur in future seasons. CONCLUSIONS: Expert estimates suggest there is a potential for 9% on average (weighted average of "All strains" over three age groups adjusted by population size) and up to a 16% increase in IVE (against A(H3N2), the <65 age group) if egg adaptations that arise when employing the traditional egg-based manufacturing process are avoided.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country: España Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country: España Country of publication: Suiza